लोड हो रहा है...
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
The efficacy of standard antidepressants is limited for many patients with mood disorders such as major depressive disorder (MDD) and bipolar depression, underscoring the urgent need to develop novel therapeutics. Both clinical and preclinical studies have implicated glutamatergic system dysfunction...
में बचाया:
| में प्रकाशित: | CNS Drugs |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8201267/ https://ncbi.nlm.nih.gov/pubmed/33904154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-021-00816-x |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|